This inventor holds 6 USPTO granted patents. Top assignees: Societe Leb-Tech, Institut Pasteur, Medisup International, N.v.. Active years: 1998-2002.
Company Filing History:
4 out of 4 
1 out of 897 
1 out of 2 
Years Active: 1998-2002
Title: The Innovations of Georges Lutfalla
Introduction
Georges Lutfalla is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and interferon receptors. With a total of 6 patents to his name, Lutfalla's work has had a considerable impact on medical diagnostics and therapeutic applications.
Latest Patents
Among his latest patents, Lutfalla has developed water-soluble polypeptides that exhibit a high affinity for both alpha and beta interferons. These innovations include DNA sequences and expression cells, along with a preparation method for drugs and compositions that utilize these polypeptides as diagnostic agents or for producing antibodies. Additionally, he has patented a purified human alpha interferon receptor, which relates to a purified receptor of human alpha interferon.
Career Highlights
Throughout his career, Georges Lutfalla has worked with various companies, including Leb-Tech and Medisup International. His expertise in biotechnology has allowed him to contribute to advancements in medical research and therapeutic solutions.
Collaborations
Lutfalla has collaborated with notable individuals in the field, including Ion Gresser and Knud Erik Mogensen. These partnerships have further enhanced his research and development efforts.
Conclusion
Georges Lutfalla's innovative work in biotechnology has led to significant advancements in the understanding and application of interferons. His contributions continue to influence the field and pave the way for future discoveries.